Abstract:Fish are poor users of dietary carbohydrates and often display prolonged hyperglycemia and fat deposition after feeding high digestible carbohydrate diets. Recently, fatty acid beta-oxidation (FAO) inhibition has been reported to increase glucose oxidation in fish. Therefore, this study tested the assumption that the inhibition of FAO with mildronate (MD, a carnitine synthesis inhibitor) might also increase glucose utilization and alleviate adverse effects induced by high starch diet (HSD) in Nile tilapia, Oreochromis niloticus. Nile tilapia juveniles (6.13 +/- 0.11 g) were cultured in nine 200-L tanks (30 fish per tank) and divided into three groups (three tanks per group). The fish were fed twice a day (9:00 and 18:30) at 4% body weight by using a normal starch diet (NSD, 30% corn starch), a HSD (45% corn starch), or a HSD supplemented with MD (25 g/kg of diet, HSD + MD) for eight weeks. These three feeds contained approximately 35.8% protein and 6.4% lipid. The fish each tank were weighed every two weeks, and the feeding amount was adjusted accordingly. After the feeding trial, the fish fed on HSD showed higher hepatosomatic index (HSI), visceral somatic index (VSI), serum triglyceride concentration and wholebody and tissue (liver and muscle) lipid contents than those fed on NSD. The fish fed on HSD also had higher relative area of vacuolation in the liver, hepatic malondialdehyde (MDA) content, and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities in the serum than those fed on NSD. Moreover, the fish fed on HSD increased serum glucose and insulin concentrations, and hepatic lactate, pyruvate and glycogen contents, but reduced whole-body protein content and dietary protein utilization than those fed on NSD, indicating that HSD induced fat deposition, liver damage, glucose intolerance and lowered protein-sparing effect. However, the fish fed on HSD + MD decreased hepatic carnitine content and FAO activity, attenuated the indexes related to fat deposition and liver damage, improved blood glucose clearance and whole-body protein deposition than those fed on HSD, suggesting that the adverse effects caused by HSD were reversed after FAO inhibition. Furthermore, the fish fed on HSD down-regulated the expression of genes associated with glucose uptake, glycolysis, FAO process, and lipolysis compared to those fed on HSD + MD and NSD, yet up-regulated lipogenic and proteolytic genes. These data suggested that inhibition of FAO improved glucose utilization and alleviated the HSD-induced adverse effects in Nile tilapia. This work demonstrates that, modifying mitochondrial FAO activity regulates the ability of fish to adapt to HSD intake through remodeling energy homeostasis. Our study provides new insights into improving carbohydrate utilization in aquatic animals.

Mitochondrial Fatty Acid Β-Oxidation Inhibition Promotes Glucose Utilization and Protein Deposition Through Energy Homeostasis Remodeling in Fish

Reduced fatty acid -oxidation improves glucose catabolism and liver health in Nile tilapia (<i>Oreochromis niloticus</i>) juveniles fed a high-starch diet

Reduced fatty acid β-oxidation improves glucose catabolism and liver health in Nile tilapia (Oreochromis niloticus) juveniles fed a high-starch diet

Dietary L-carnitine Improves Glycogen and Protein Accumulation in Nile Tilapia Via Increasing Lipid-Sourced Energy Supply: an Isotope-Based Metabolic Tracking

Inhibited Carnitine Synthesis Impairs Adaptation to High-Fat Diet in Nile Tilapia (oreochromis Niloticus)

Inhibited Carnitine Synthesis Causes Systemic Alteration of Nutrient Metabolism in Zebrafish.

Peroxisomal proliferator-activated receptor -b deficiency induces the reprogramming of nutrient metabolism in zebrafish

Inhibition of mitochondrial fatty acid β-oxidation activates mTORC1 pathway and protein synthesis via Gcn5-dependent acetylation of Raptor in zebrafish

Impaired Peroxisomal Fat Oxidation Induces Hepatic Lipid Accumulation and Oxidative Damage in Nile Tilapia

Inhibited Fatty Acid Β-Oxidation Impairs Stress Resistance Ability in Nile Tilapia (oreochromis Niloticus)

The reduction of lipid-sourced energy production caused by ATGL inhibition cannot be compensated by activation of HSL, autophagy, and utilization of other nutrients in fish

Gene Expression Patterns Indicate That a High-Fat-high-carbohydrate Diet Causes Mitochondrial Dysfunction in Fish.

Dietary sodium lactate promotes protein and lipid deposition through increasing energy supply from glycolysis in Nile tilapia (Oreochromis niloticus)

Muscle Metabolism in Response to Oxidized Fish Oil Feed in Juvenile Nile Tilapia

Peroxisomal proliferator-activated receptor α-b deficiency induces the reprogramming of nutrient metabolism in zebrafish

Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio

Inhibiting mitochondrial citrate shuttling induces hepatic triglyceride deposition in Nile tilapia (Oreochromis niloticus) through lipid anabolic remodeling

Systemic Effect of Dietary Lipid Levels and Α-Lipoic Acid Supplementation on Nutritional Metabolism in Zebrafish ( Danio Rerio ): Focusing on the Transcriptional Level

Inhibited Autophagy Impairs Systemic Nutrient Metabolism in Nile Tilapia

SIRT1-NRF2-TFEB Axis-Mediated Hepatic Lipophagy Alleviates the Lipid Deposition Induced by High Glucose in Yellow Catfish Pelteobagrus Fulvidraco.

Mechanisms and metabolic regulation of PPARα activation in Nile tilapia (Oreochromis niloticus)